loader
Please Wait
Applying Filters...
menu
    • menu

    List of Written Confirmation(s) issued for Glucosamine Sulfate Sodium Chloride Active Pharmaceutical Ingredient (API)

    Client Email Product
    2024 US Elections: Harris, Trump differ on abortion rights, ACA, public health spends; agree on need to cut drug prices

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Aug 2024: Otsuka buys Jnana, Lilly’s market cap gains by over US$ 108 bn post new guidance

    Stock Recap
    #PipelineProspector

    Menu

    Glucosamine Sulfate Sodium Chloride

    ACTIVE PHARMA INGREDIENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 11Xls download

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Name of the Firm Written Confirmation No. Product Name Issue Date Valid Till Address of the Firm
    08/05/2021 Andhra Medi pharma
    India
    		 M/s Andhra Medi pharma WC-0302 Glucosamine Sulphate Sodium Chloride USP/EP 2021-03-22 2024-03-04 Sy. No.263 Veeravalli village Bapulapadu mandal 521110 Andhra Pradesh
    10/11/2020 Beloorbayir Biotech
    India
    		 M/s. Beloorbayir Biotech Ltd WC-233 Glucosamine Sulfate Sodium Chloride USP 2020-03-26 2022-07-02 No.10, 13th Cross, 34th Ward, Doddanna Industrial Estate, Near Peenya 2nd Stage, Bangalore-560091